tiprankstipranks
Trending News
More News >
Eyepoint Pharma (EYPT)
:EYPT
US Market
Advertisement

EyePoint Pharmaceuticals (EYPT) Technical Analysis

Compare
950 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Eyepoint Pharma’s (EYPT) Moving Averages Convergence Divergence (MACD) indicator is -0.35, suggesting Eyepoint Pharma is a Buy.
Eyepoint Pharma’s (EYPT) 20-Day exponential moving average is 12.08, while Eyepoint Pharma’s (EYPT) share price is $11.08, making it a Sell.
Eyepoint Pharma’s (EYPT) 50-Day exponential moving average is 12.20, while Eyepoint Pharma’s (EYPT) share price is $11.08, making it a Sell.

EyePoint Pharmaceuticals (EYPT) Pivot Points

Nov 09, 2025, 02:46 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.49
10.17
10.63
11.31
11.77
12.45
12.91
Fibonacci
10.17
10.61
10.88
11.31
11.75
12.02
12.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

EyePoint Pharmaceuticals (EYPT) Moving Averages

Nov 09, 2025, 02:46 AM
Period
Simple
Exponential
MA5
11.63Sell
11.50Sell
MA10
11.95Sell
11.77Sell
MA20
11.99Sell
12.08Sell
MA50
12.83Sell
12.20Sell
MA100
11.60Sell
11.43Sell
MA200
9.09Buy
9.85Buy
Eyepoint Pharma’s (EYPT) 10-Day exponential moving average is 11.77, while Eyepoint Pharma’s (EYPT) share price is $11.08, making it a Sell.
Eyepoint Pharma’s (EYPT) 100-Day exponential moving average is 11.43, while Eyepoint Pharma’s (EYPT) share price is $11.08, making it a Sell.
Eyepoint Pharma’s (EYPT) stock price is $11.08 and Eyepoint Pharma’s (EYPT) 50-day simple moving average is 12.83, creating a Sell signal.
Eyepoint Pharma’s (EYPT) stock price is $11.08 and Eyepoint Pharma’s (EYPT) 100-day simple moving average is 11.60, creating a Sell signal.
Eyepoint Pharma’s (EYPT) stock price is $11.08 and Eyepoint Pharma’s (EYPT) 200-day simple moving average is 9.09, creating a Buy signal.

EyePoint Pharmaceuticals (EYPT) Technical Indicators

Nov 09, 2025, 02:46 AM
Name
Value
Implied Action
RSI (14)
40.58
Neutral
STOCH (9,6)
39.39
Neutral
STOCHRSI (14)
39.39
Neutral
MACD (12,26)
-0.35
Buy
ADX (14)
23.57
Neutral
Williams %R
-57.72
Buy
CCI (14)
-146.32
Buy
ATR (14)
0.97
-
Ultimate Oscillator
54.18
Neutral
ROC
-6.82
Sell
Eyepoint Pharma’s (EYPT) Relative Strength Index (RSI) is 40.58, creating a Neutral signal.
Eyepoint Pharma’s (EYPT) Trend Strength Indicator (ADX) is 23.57, creating a Neutral signal.
Eyepoint Pharma’s (EYPT) Commodity Channel Index (CCI) is -146.32, creating a Buy signal.
Eyepoint Pharma’s (EYPT) Price Rate of Change (ROC) is -6.82, creating a Sell signal.

FAQ

Is EYPT a Buy, Hold, or Sell?
Based on EYPT’s technical indicators, EYPT is a Sell.
    What is EYPT’s RSI (14)?
    EYPT’s RSI (14) is 40.58, which suggests EYPT is a Neutral.
      What is EYPT’s MACD?
      EYPT’s MACD is -0.35, which suggests EYPT is a Buy.
        What is EYPT’s 5-day moving average?
        EYPT’s 5-day moving average is 11.63, which suggests EYPT is a Sell.
          What is EYPT’s 20-day moving average?
          EYPT 20-day moving average is 11.99, which suggests EYPT is a Sell.
            What is EYPT’s 50-day moving average?
            EYPT’s 50-day moving average is 12.83, which suggests EYPT is a Sell.
              What is EYPT’s 200-day moving average?
              EYPT’s 200-day moving average is 9.09, which suggests EYPT is a Buy.
                What is EYPT’s Williams % R (14)?
                EYPT’s Williams % R (14) is -57.72, which suggests EYPT is a Buy.
                  What is EYPT’s CCI (14)?
                  EYPT’s CCI (14) is -146.32, which suggests EYPT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis